Covered recipient · General Payments record
ROGER ALAN GOLDBERG
Allopathic & Osteopathic Physicians Ophthalmology Retina Specialist
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2024 · Entire year
$216,129.82
172 records · 0 disputed
Other CMS categories — not shown on this page
Research Payments
CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Ownership and Investment Interests
CMS also publishes Ownership and Investment Interests as a separate dataset. This site does not currently mirror it, and no ownership figure is shown on this page. This provider appears in that dataset.
Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.
These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2024 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $133,050.58 | 61 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58,284.00 | 12 |
| Travel and Lodging | $20,409.10 | 33 |
| Food and Beverage | $2,846.14 | 64 |
| Honoraria | $1,390.00 | 1 |
| Gift | $150.00 | 1 |
By paying entity
PY2024 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | $71,810.45 | 47 |
| Boehringer Ingelheim International GmbH | $49,654.47 | 15 |
| Genentech USA, Inc. | $30,787.80 | 30 |
| EyePoint Pharmaceuticals US, Inc. | $17,314.61 | 14 |
| Regeneron Pharmaceuticals, Inc. | $15,077.82 | 15 |
| Ocular Therapeutix, Inc. | $11,760.52 | 7 |
| Regeneron Healthcare Solutions, Inc. | $3,377.47 | 10 |
| ABBVIE INC. | $3,235.17 | 6 |
| BioCryst Pharmaceuticals, Inc. | $3,117.88 | 4 |
| Genentech, Inc. | $2,960.93 | 4 |
| Carl Zeiss Meditec, Inc. | $2,720.00 | 1 |
| Beaver-Visitec International, Inc. | $1,500.00 | 1 |
| Alimera Sciences, Inc. | $1,479.79 | 4 |
| Carl Zeiss Meditec USA, Inc. | $680.00 | 1 |
| Astellas Pharma US Inc | $390.50 | 8 |
| Avirmax Biopharma, Inc | $181.49 | 2 |
| Coherus Biosciences Inc. | $30.53 | 1 |
| ANI Pharmaceuticals, Inc. | $28.13 | 1 |
| Amgen Inc. | $22.26 | 1 |
Page 1 of 4; records 1–50 of 172 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
ROGER ALAN GOLDBERG
NPI 1184866584 · CMS profile ID 368636
Allopathic & Osteopathic Physicians / Ophthalmology / Retina Specialist
WALNUT CREEK, CA
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 1 of 4; records 1–50 of 172 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1184866584?year=2024&recipient=provider#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- ROGER ALAN GOLDBERG, NPI 1184866584, CMS profile ID 368636. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 4; records 1–50 of 172 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1184866584?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
- APA 7
- IndustryPayments. (2026). ROGER ALAN GOLDBERG, NPI 1184866584, CMS profile ID 368636. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 4; records 1–50 of 172 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1184866584?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
- Bluebook
- ROGER ALAN GOLDBERG, NPI 1184866584, CMS profile ID 368636, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 4; records 1–50 of 172 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1184866584?year=2024&recipient=provider#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2024
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30
172 matching records · $216,129.82 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 1–50 of 172.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Beaver-Visitec International, Inc. | $1,500.00 | 12/31/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1146937996 | CMS |
| Avirmax Biopharma, Inc | $150.00 | 12/20/2024 | Gift | No dispute reported | Delay: No Change: NEW | 06/30/2026 | 1237000380 | CMS |
| Regeneron Pharmaceuticals, Inc. | $1,880.00 | 12/20/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1114399347 | CMS |
| Regeneron Pharmaceuticals, Inc. | $2,350.00 | 12/20/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1114399349 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $9,250.00 | 12/17/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089507310 | CMS |
| Apellis Pharmaceuticals, Inc. | $31.12 | 12/16/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1154028747 | CMS |
| Apellis Pharmaceuticals, Inc. | $946.00 | 12/13/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1154028763 | CMS |
| Apellis Pharmaceuticals, Inc. | $946.00 | 12/13/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1154028781 | CMS |
| Genentech, Inc. | $840.00 | 12/12/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1133100903 | CMS |
| Ocular Therapeutix, Inc. | $2,000.00 | 12/12/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1148202981 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $109.72 | 12/11/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089506908 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $125.00 | 12/10/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089508058 | CMS |
| Regeneron Healthcare Solutions, Inc. | $470.00 | 12/06/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1114057144 | CMS |
| Genentech USA, Inc. | $20.49 | 12/05/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1133100883 | CMS |
| Genentech USA, Inc. | $3.73 | 12/05/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1133100887 | CMS |
| ANI Pharmaceuticals, Inc. | $28.13 | 12/02/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1091140994 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $462.50 | 12/02/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089507572 | CMS |
| Boehringer Ingelheim International GmbH | $950.00 | 11/26/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1117908666 | CMS |
| Apellis Pharmaceuticals, Inc. | $21.71 | 11/22/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1154028773 | CMS |
| Regeneron Healthcare Solutions, Inc. | $36.61 | 11/22/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1114057142 | CMS |
| ABBVIE INC. | $24.15 | 11/19/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1103810302 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $939.18 | 11/16/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089507492 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $206.13 | 11/16/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089508148 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $401.18 | 11/15/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089507626 | CMS |
| ABBVIE INC. | $4.29 | 11/14/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1103810300 | CMS |
| Boehringer Ingelheim International GmbH | $475.00 | 11/14/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1117908658 | CMS |
| Apellis Pharmaceuticals, Inc. | $4,257.00 | 11/13/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1154028771 | CMS |
| Genentech, Inc. | $10.74 | 11/13/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1133100895 | CMS |
| Ocular Therapeutix, Inc. | $2,500.00 | 11/12/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1148202977 | CMS |
| Astellas Pharma US Inc | $33.50 | 11/07/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1139435702 | CMS |
| Apellis Pharmaceuticals, Inc. | $34.61 | 11/06/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1154028745 | CMS |
| BioCryst Pharmaceuticals, Inc. | $950.00 | 11/06/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1117474678 | CMS |
| Boehringer Ingelheim International GmbH | $1,187.50 | 11/06/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1117908668 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $462.50 | 11/01/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089508144 | CMS |
| Astellas Pharma US Inc | $26.50 | 10/31/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1139443458 | CMS |
| Apellis Pharmaceuticals, Inc. | $473.00 | 10/30/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1154028761 | CMS |
| Boehringer Ingelheim International GmbH | $3,375.00 | 10/24/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1117908678 | CMS |
| Genentech USA, Inc. | $27.71 | 10/24/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1133100879 | CMS |
| Alimera Sciences, Inc. | $29.48 | 10/23/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1092828699 | CMS |
| Genentech, Inc. | $2,100.00 | 10/22/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1133100899 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $78.95 | 10/19/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089506924 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $114.87 | 10/19/2024 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089507476 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $1,387.50 | 10/19/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089507872 | CMS |
| Ocular Therapeutix, Inc. | $1,000.00 | 10/19/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1148202983 | CMS |
| Apellis Pharmaceuticals, Inc. | $144.40 | 10/18/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1154028779 | CMS |
| Ocular Therapeutix, Inc. | $3,500.00 | 10/18/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1148202973 | CMS |
| Apellis Pharmaceuticals, Inc. | $1,500.00 | 10/16/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1154028775 | CMS |
| Genentech USA, Inc. | $23.90 | 10/10/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1133100875 | CMS |
| Apellis Pharmaceuticals, Inc. | $27.96 | 10/09/2024 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1154028711 | CMS |
| EyePoint Pharmaceuticals US, Inc. | $2,158.33 | 10/01/2024 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 1089508094 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.